Xtant Other Operating Expenses from 2010 to 2024
| XTNT Stock | USD 0.40 0.01 2.44% |
Other Operating Expenses | First Reported 2008-09-30 | Previous Quarter 32.9 M | Current Value 31.7 M | Quarterly Volatility 8.3 M |
Check Xtant Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Xtant Medical's main balance sheet or income statement drivers, such as Interest Expense of 5.3 M, Total Revenue of 53.7 M or Gross Profit of 34 M, as well as many indicators such as Price To Sales Ratio of 1.4, Dividend Yield of 0.0 or PTB Ratio of 2.49. Xtant financial statements analysis is a perfect complement when working with Xtant Medical Valuation or Volatility modules.
Xtant | Other Operating Expenses |
Latest Xtant Medical's Other Operating Expenses Growth Pattern
Below is the plot of the Other Operating Expenses of Xtant Medical Holdings over the last few years. Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Xtant Medical Holdings. It is also known as Xtant Medical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. It is expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production. Xtant Medical's Other Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Xtant Medical's overall financial position and show how it may be relating to other accounts over time.
| Other Operating Expenses | 10 Years Trend |
|
Other Operating Expenses |
| Timeline |
Xtant Other Operating Expenses Regression Statistics
| Arithmetic Mean | 60,294,448 | |
| Geometric Mean | 44,176,555 | |
| Coefficient Of Variation | 44.78 | |
| Mean Deviation | 20,242,706 | |
| Median | 60,433,394 | |
| Standard Deviation | 26,997,048 | |
| Sample Variance | 728.8T | |
| Range | 101M | |
| R-Value | 0.61 | |
| Mean Square Error | 491T | |
| R-Squared | 0.37 | |
| Significance | 0.02 | |
| Slope | 3,693,802 | |
| Total Sum of Squares | 10203.8T |
Xtant Other Operating Expenses History
About Xtant Medical Financial Statements
Xtant Medical shareholders use historical fundamental indicators, such as Other Operating Expenses, to determine how well the company is positioned to perform in the future. Although Xtant Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Xtant Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Xtant Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Other Operating Expenses | 101.5 M | 60.4 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Xtant Stock Analysis
When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.